Radan, Princess Michaella .

HRN: 26-80-19  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2025
CEFUROXIME 750MG (VIAL)
09/27/2025
10/04/2025
IV
250mg
Q8
PCAP C; Cellulitis
Remove - Pending Acceptance
09/27/2025
MUPIROCIN 2%, 15G (TUBE)
09/27/2025
10/04/2025
TOPICAL
15g
TID
Cellulitis
Remove - Pending Acceptance
09/29/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/29/2025
10/06/2025
IV
340mg
Q6
PCAP; CELLULITIS
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: